HAILEY STURM: Open Payments
NPI 1003472242 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,266 in 54 payments from 24 companies in 2025. Trend: 2023 $384 · 2024 $1,198 · 2025 $1,266
Food & beverage: $1,058Education: $208
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $186 |
| Aveo Pharmaceuticals, Inc. | 4 | $136 |
| AstraZeneca Pharmaceuticals LP | 5 | $103 |
| SEAGEN INC. | 1 | $100 |
| GENZYME CORPORATION | 4 | $92 |
| PFIZER INC. | 4 | $78 |
| Syndax Pharmaceuticals, Inc. | 2 | $57 |
| Incyte Corporation | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| Janssen Biotech, Inc. | 3 | $50 |
Products named: FOTIVDA, KISQALI, SARCLISA, TAGRISSO, FRUZAQLA, XTANDI, KEYTRUDA, ERLEADA.
Industry payments across IN — which companies pay providers there.
